Cerebain Biotech Corp (fka CBBT) (CBBT)

[Jack Torrance]

We're all bag holders now, whether we like it or not. Thing is, none of the due diligence has changed. There is still an acquisition only a hair from closing. There is still a tech company that makes good revenue. And there is still the potential of the Alzheimer's device. Selling now is near to a total loss for a lot of us, so the only logical thing to do is to just hold. Set a price alert and walk away.